Options Price a Wide One-Year Range for Boston Scientific

Options on Boston Scientific (NYSE: BSX) implied a one-year share-price range of $28.46 to $67.16, based on a September 22 share price of $43.72. The range comes as the stock has lost 55.5% over the past 12 months.

The estimate uses 43.1% implied volatility, an annualized measure of the movement traders expect. It describes a roughly two-thirds chance of the stock ending within that band, assuming typical market conditions.

The range is not a price target or a hard floor and ceiling. Its lower end is about 35% below the reference price; its upper end is about 54% higher. Shares can finish outside either level.

Options imply only slightly more volatility than BSX’s 38.4% realized volatility over the past year. But that period already included the stock’s steep decline, so the comparison points to continued turbulence, not a calm return to normal.

Company results explain some of the uncertainty. Boston Scientific reported $5.44 billion in second-quarter sales, up 7% organically, and adjusted earnings of 86 cents per share. In July, it cut its 2026 organic sales-growth forecast to 5%–6%.

Management pointed to weaker-than-expected U.S. demand for WATCHMAN, its heart implant for reducing stroke risk, and slower U.S. growth in electrophysiology. Those pressures hit two businesses investors had counted on to drive growth.

A cyberattack added another risk. On September 8, the company warned the disruption was likely to materially affect third-quarter and full-year results, and said it was unlikely to meet its previous guidance. A September 22 investigation update found no evidence of continued attacker activity after containment.

The next major test is Boston Scientific’s planned October 28 results call. Investors will be watching for revised forecasts and signs that the company can recover disrupted sales while addressing the slowdown in its key businesses.